CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income		$ 966	$ 892	$ 835
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income taxes		(9)	(27)	(44)
Provision for inventories		42	43	39
Depreciation and amortization		829	95	90
Amortization of capitalized software development costs and intellectual property licenses	[1]	321	399	256
Premium payment for early redemption of note (see Note 11)		63	0	0
Amortization of debt discount, financing costs, and non-cash write-off due to extinguishment of debts		50	7	7
Share-based compensation expense	[2]	147	92	104
Other		4	0	1
Changes in operating assets and liabilities, net of effect from business acquisitions:
Accounts receivable, net		84	(40)	(177)
Inventories		32	(54)	(2)
Software development and intellectual property licenses		(362)	(350)	(349)
Other assets		(10)	21	18
Deferred revenues		(35)	(27)	475
Accounts payable		(50)	(25)	(12)
Accrued expenses and other liabilities		83	233	90
Net cash provided by operating activities		2,155	1,259	1,331
Cash flows from investing activities:
Proceeds from maturities of available-for-sale investments		0	145	21
Purchases of available-for-sale investments		0	(145)	0
Acquisition of business, net of cash acquired (see Note 21)		(4,588)	(46)	0
Release (deposit) of cash in escrow		3,561	(3,561)	0
Capital expenditures		(136)	(111)	(107)
Other investing activities		(14)	2	2
Net cash used in investing activities		(1,177)	(3,716)	(84)
Cash flows from financing activities:
Proceeds from issuance of common stock to employees		106	106	175
Tax payment related to net share settlements on restricted stock rights		(115)	(83)	(66)
Dividends paid		(195)	(170)	(147)
Proceeds from debt issuances, net of discounts		6,878	0	0
Repayment of long-term debt		(6,104)	(250)	(375)
Debt financing costs related to debt issuances		(7)	(7)	0
Premium payment for early redemption of note (see Note 11)		(63)	0	0
Proceeds received from shareholder settlement (see Note 19)		0	202	0
Net cash provided by (used in) financing activities		500	(202)	(413)
Effect of foreign exchange rate changes on cash and cash equivalents		(56)	(366)	(396)
Net increase (decrease) in cash and cash equivalents		1,422	(3,025)	438
Cash and cash equivalents at beginning of period		1,823	4,848	4,410
Cash and cash equivalents at end of period		$ 3,245	$ 1,823	$ 4,848

[1] Excludes deferral and amortization of share-based compensation expense.

[2] Includes the net effects of capitalization, deferral, and amortization of share-based compensation expense.